News Summary
New York Attorney General Letitia James announced the state has secured nearly $39 million from settlements with eight major drug companies to address the opioid crisis. This funding will bolster the state’s existing $3 billion opioid settlement fund, aimed at enhancing prevention and treatment initiatives. With a focus on reducing overdose fatalities and improving access to treatments, these funds will support local substance use programs and mitigate the impact of potential federal Medicaid cuts on addiction coverage.
New York – New York Attorney General Letitia James announced that the state has secured nearly $39 million as part of legal agreements with eight major drug companies, aimed at addressing the ongoing opioid crisis. These funds are expected to start flowing into the state’s opioid settlement fund as early as next year, contributing to the state’s efforts to combat addiction and support treatment programs.
The recent settlement adds to New York’s existing fund of over $3 billion already earmarked for opioid prevention and treatment initiatives. This settlement is part of a larger $720 million pool resulting from negotiations between multiple states, including other impacted areas such as California, Colorado, and Illinois. To date, New York’s Office of Addiction Services and Supports has received approximately $505 million, allowing significant investments into local substance use programs, particularly in distributing overdose-reversing medications like naloxone.
Out of the total funds received, around $407 million has been allocated for various substance use programs that benefit counties and local providers. These funded initiatives are designed to improve community access to essential treatments while reducing barriers to medication-assisted therapies.
A key stipulation of the settlement mandates that state officials must deploy the settlement funds specifically toward innovative strategies focused on reducing overdose-related fatalities. Existing funding streams must not be replaced by these new resources, ensuring that the funds directly contribute to enhancing the effectiveness of overdose prevention efforts.
New York faces an added challenge as potential federal Medicaid cuts cast uncertainty over the ongoing substance use treatment landscape, which could jeopardize coverage for approximately 1.5 million state residents. Experts advocate for a well-formulated strategy to maximize the use of these settlement funds, particularly in light of the anticipated federal funding reductions that may impact addiction treatments.
The situation has been characterized as a “warning bell” by seasoned professionals in order to highlight the urgency in addressing the challenges posed by potential federal cuts. While it remains unclear what precise effects these cuts may have, addiction patients may still retain exemptions from certain work requirements, indicating potential complexities ahead.
Tracie Gardner, an advisory board member for the opioid settlement fund, emphasized the importance of rapidly disbursing these funds to effectively meet community needs, underscoring the pressing nature of the opioid crisis. Additionally, experts like Robert Kent, formerly the general counsel at the state Office of Addiction Services and Supports, noted that the settlement funds might also be directed toward supporting job creation programs for those in recovery, which could require an investment exceeding $50 million.
The disbursement of funds from the latest settlement agreements will occur over the next decade. The largest financial contributor to the settlement is Mylan, now part of Viatris, which will be paying nearly $285 million across several states over the span of ten years. Other companies involved in these significant settlements include Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus, all of which will face strict marketing limitations and restrictions against producing high-oxycodone medications as part of the settlement terms.
This funding represents a crucial step for New York in its efforts to bolster the state’s defenses against the opioid crisis, aiming to provide comprehensive support services for individuals battling addiction and reduce the incidence of overdose deaths across communities.
Deeper Dive: News & Info About This Topic
HERE Resources
Extend Raises $50 Million to Transform Business Payments
Purdue Pharma Settlement Nears Approval Amid Opioid Crisis
New York Secures $250 Million in Opioid Settlement
Rite Aid to Close All New York Stores Amid Bankruptcy
Additional Resources
- Crain’s New York: New York Finalizes Settlement Deals with Opioid Companies
- Wikipedia: Opioid Epidemic
- WRFALP: NYS Attorney General Announces Opioid Settlement of $720 Million
- Encyclopedia Britannica: Opioid Addiction
- Virginia Mercury: Virginia Lands $16.4M from New Opioid Settlement
- Google Search: Opioid Settlement
Author: STAFF HERE NEW YORK WRITER
NEW YORK STAFF WRITER The NEW YORK STAFF WRITER represents the experienced team at HERENewYork.com, your go-to source for actionable local news and information in New York, the five boroughs, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as New York Fashion Week, Macy's Thanksgiving Day Parade, and Tribeca Film Festival. Our coverage extends to key organizations like the Greater New York Chamber of Commerce and United Way of New York, plus leading businesses in finance and media that power the local economy such as JPMorgan Chase, Goldman Sachs, and Bloomberg. As part of the broader HERE network, including HEREBuffalo.com, we provide comprehensive, credible insights into New York's dynamic landscape.
